Business Weekly newspaper’s Post

View organization page for Business Weekly newspaper, graphic

12,769 followers

Three VC investors with Cambridge operations – Amadeus Capital Partners, Cambridge Innovation Capital and IQ Capital – are among 20 of the UK’s leading Venture Capital and Growth Equity firms fighting to unlock British pension investment in high growth companies through a unique initiative. https://lnkd.in/dzMF7-rF The trio help provide the backbone to the new Venture Capital Investment Compact engineered by the British Private Equity & Venture Capital Association (BVCA). The Compact commits signatories to working closely with the pension funds which were enlisted in the Government’s Mansion House agreement. Earlier this summer, the City of London Corporation coordinated the Mansion House agreement, committing nine of the UK’s largest pension funds to the objective of allocating at least five per cent of their default funds to unlisted equities by 2030. The new Venture Capital Investment Compact builds on that agreement and will help to unlock over £50bn of new capital by the end of the decade. BVCA chief executive Michael Moore, said: “Many overseas investors have jumped at the chance to invest in – and benefit from – the performance of innovative UK firms. UK savers must have access to the same opportunity. “We want to seize this opportunity for British pension savers to benefit from returns garnered from VC innovation in the UK, while helping businesses to grow, succeed and create jobs.” Andrew Williamson, Managing Partner of Cambridge Innovation Capital and Chair of the BVCA’s Venture Capital Committee added: “The Compact demonstrates that the VC industry is committed to partnering with pension schemes to help them address the barriers they face when allocating to this asset class, in order to allow savers to benefit from the higher potential net returns that can arise from investment in unlisted equity such as private capital funds as part of a diversified portfolio.” Life sciences and DeepTech companies could benefit hugely from the new initiative. Steve Bates OBE FMedSci, CEO of the UK BioIndustry Association (BIA) said: “Nearly two-thirds of pension savers recently surveyed said they want to know where their money is being invested. “The detail matters – people need to know if their money is being invested in another online betting app or a company from Cambridge that is trying to understand why some people survive cancer whilst others die, with the aim of developing therapies that will allow us all to survive. “Alchemab Therapeutics Ltd in Cambridge and many other companies recently identified by global consultants PwC as the most innovative and groundbreaking life science companies operating in the UK right now, have the potential to transform patient care in the NHS and become global success stories, delivering the return on investment that pension savers need for their retirement. “The Compact is a critical step to unlock new capital to accelerate their growth and to realise those ambitions.”

Cambridge trio help boost pension fund investment in high-growth companies in £50bn play

Cambridge trio help boost pension fund investment in high-growth companies in £50bn play

businessweekly.co.uk

To view or add a comment, sign in

Explore topics